Denali Therapeutics
Price & Volume
Stats
See moreOpen | $18.97 |
Previous Close | $18.89 |
Day Range | $18.47-$18.97 |
52W Range | $15.34-$27.30 |
Market Cap | $3B |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $21.3M |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$392.2M |
Diluted EPS | -$1.72 |
News
See moreYahoo Finance • 10 days ago
Here are the major earnings after the close Tuesday
Yahoo Finance • last month
Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation | DelveInsight
Yahoo Finance • 3 months ago
Real Parkinson’s Disease Hope from Jupiter Neurosciences
Yahoo Finance • 3 months ago
Denali Therapeutics (DNLI) Q2 2026 Earnings Call Transcript
About
CEO | Dr. Ryan J. Watts Ph.D. |
CFO | Dr. Alexander O. Schuth M.D., Ph.D. |
Address | 161 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 503 |